DTC advertising harms patients and should be tightly regulated

Journal of Law, Medicine and Ethics

Volumn 37, Issue 3, 2009, Pages 444-450

  Lurie, Peter ^a  

^a Public Citizen Health Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; CONFERENCE PAPER; CONSUMER ADVOCACY; DRUG CONTROL; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; HUMAN; LEGAL ASPECT; UNITED STATES;

ADVERTISING AS TOPIC; CONSUMER ADVOCACY; DRUG AND NARCOTIC CONTROL; DRUG INDUSTRY; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 69649101898     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2009.00405.x     Document Type: Conference Paper

References (39)

1. J. M. Donohue, M. Cevasco, and M. B. Rosenthal A Decade of Direct-to-Consumer Advertising of Prescription Drugs New England Journal of Medicine 357, no. 7 (2007 673 681.
2. Guidance for Industry: Consumer-Directed Broadcast Advertisements Food and Drug Administration, August 1999, available at http://www.fda.gov/cder/ guidance/1804fnl.htm last visited May 21, 2009).
3. L. Toop and D. Mangin Industry Funded Patient Information and the Slippery Slope to New Zealand British Medical Journal 335, no. 7622 (2007 694 695.
4. M. F. Hollon Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion Journal of the American Medical Association 293, no. 16 (2005 2030 2033.
5. National Institute for Health Care Management Prescription Drugs and Mass Media Advertising, 2000 2001, available at http://www.nihcm.org/∼nihcmor/ pdf/DTCbrief2001.pdf last visited May 22, 2009).
6. D. J. Graham, D. Campen, and R. Hui et al. Risk of Acute Myocardial Infarction and Sudden Cardiac Death in Patients Treated with Cyclo-Oxygenase 2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs: Nested Case-Control Study The Lancet 365, no. 9458 (2005 475 481.
7. M. M. Spence, S. S. Teleki, T. C. Cheetham, S. O. Schweitzer, and M. Millares Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing Medical Care Research and Review 62, no. 5 (2005 544 559.
8. W. D. Bradford, A. N. Kleit, P. J. Nietert, T. Steyer, T. McIlwain, and S. Ornstein How Direct-to-Consumer Television Advertising for Osteoarthritis Drugs Affects Physicians' Prescribing Behavior Health Affairs 25, no. 5 (2006 1371 1377.
9. Galderma website, available at http://www.differin.com/teens/index.shtml last visited May 21, 2009).
10. S. M. Wolfe, Letter to FDA Urging Action on Misleading CRESTOR Advertising by AstraZeneca (HRG Publication 1712), available at http://www.citizen.org/publications/release.cfm?ID=7347 last visited May 21, 2009).
11. C. H. Smith, Division of Drug Marketing, Advertising and Communications, Letter to Mark R. Szewczak, AstraZeneca, Food and Drug Administration, December 21, 2004, available at http://www.fda.gov/cder/warn/2004/12779.pdf last visited May 22, 2009).
12. S. Saul Drug Ads Raise Questions for Heart Pioneer New York Times, February 7, 2008, at A1
13. S. Saul, "Pfizer to End Lipitor Ads by Jarvik," New York Times, February 26, 2008, at C1.
14. S. E. Gollust, S. C. Hull, and B. S. Wilfond Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing Journal of the American Medical Association 288, no. 14 (2002 1762 1767.
15. CyGene Direct website, available at https://cygenedirect.com/athletic- performance/dna-testing-athletic-performance.html last visited May 22, 2009.).
16. Suracell website, available at http://www.suracell.com/faqs/#1 last visited May 22, 2009).
17. General Accounting Office Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising has Limitations GAO-03-177, October 2002, available at http://www.gao.gov/new.items/d03177.pdf last visited June 12, 2009).
18. R. A. Bell, R. L. Kravitz, and M. S. Wilkes Direct-to-Consumer Prescription Drug Advertising and the Public Journal of General Internal Medicine 14, no. 11 (1999 651 657.
19. K. J. Aikin, J. L. O. Swasy, and A. C. Braman Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs - Summary of FDA Survey Research Results Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, November 19, 2004, available at http://www.fda.gov/cder/ddmac/researchka.htm last visited May 22, 2009).
20. Id.
21. R. L. Kravitz, R. M. Epstein, and M. D. Feldman et al. Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial Journal of the American Medical Association 293, no. 16 (2005 1995 2002.
22. B. Mintzes, M. L. Barer, and R. L. Kravitz et al. How Does Direct-to-Consumer Advertising (DTCA) Affect Prescribing? A Survey in Primary Care Environments With and Without Legal DTCA Canadian Medical Journal 169, no. 5 (2003 405 412.
23. National Institute for Health Care Management, Prescription Drugs and Mass Media Advertising, September 2000, available at http://www.nihcm.org/ ∼nihcmor/pdf/DTCbrief.pdf last visited May 22, 2009).
24. Kaiser H.J. Family Foundation Impact of Direct-to-Consumer Advertising on Prescription Drug Spending 2003, available at http://www.kff.org/rxdrugs/6084- index.cfm last visited May 22, 2009).
25. See General Accounting Office, supra note 16.
26. See Aikin, supra note 18.
27. S. Gilbody, P. Wilson, and I. Watt Benefits and Harms of Direct to Consumer Advertising: A Systematic Review Quality & Safety in Health Care 14, no. 4 (2005 246 250.
28. See Kravitz, supra, note 20.
29. Pharmaceutical Research and Manufacturers Association PhRMA Guiding Principles: Direct to Consumer Advertisements about Prescription Medicines 2005, available at http://www.phrma.org/mediaroom/press/releases/02.08.2005.1195.cfm last visited May 22, 2009).
30. L. D. Sasich and S. M. Wolfe Deficiencies in Patient Information Leaflets Concerning Gastrointestinal Complications of Nonsteroidal Anti-Inflammatory Drugs Journal of General Internal Medicine 12, Supplement (1997 79 (abstract)
31. L. R. Bradley and L. D. Sasich, "The Information Content of Patient Medication Information Leaflets: Examination of Five Fluoro-quinolone Antibiotics," Journal of the American Pharmaceutical Association 38, no. 2 (1998): 278-279 (abstract)
32. S. M. Wolfe and L. D. Sasich, "Comments before FDA Hearing on Current Status of Useful Written Prescription Drug Information for Consumers, July 31, 2003 (HRG Publication 1672), available at http://www.citizen.org/ publications/release.cfm?ID=7269 last visited March 13, 2008).
33. F. J. Ingelfinger Advertising: Informational but Not Educational New England Journal of Medicine 286, no. 24 (1972 1318 1319.
34. Food and Drug Administration Guidance for Industry: Consumer-Directed Broadcast advertisements," Division of Drug Marketing, Advertising and Communications, 1999, available at http://www.fda.gov/cder/guidance/1804fnl.htm last visited May 21, 2009)
35. Food and Drug Administration, "Guidance for Industry: "Help-Seeking" and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms," Division of Drug Marketing, Advertising and Communications, 2004, available at < http://www.fda.gov/cder/guidance/ 6019dft.htm > (last visited May 22, 2009)
36. Food and Drug Administration, "Guidance for Industry: Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements," Division of Drug Marketing, Advertising and Communications, 2004, available at http://www.fda.gov/cder/guidance/guidance.htm > (last visited May 22, 2009).
37. See General Accounting Office, supra note 16.
38. Anon FDA Enforcement Actions Against False and Misleading Prescription Drug Advertisements Declined in 2003 Minority Staff of United States House of Representatives Committee on Government Reform, 2004, available at http://www.democrats.reform.house.gov/story.asp?ID=440&Issue= Prescription+Drugs last visited May 22, 2009).
39. Division of Drug Marketing, Advertising and Communications, "Warning Letters and Notice of Violation Letters to Pharmaceutical Companies Food and Drug Administration, available at http://www.fda.gov/cder/warn/index.htm last visited May 22, 2009).